Askie L M, Henderson-Smart D J
NSW Centre for Perinatal Health Services Research, Building DO2, University of Sydney, NSW, Australia, 2006.
Cochrane Database Syst Rev. 2000;2001(2):CD001076. doi: 10.1002/14651858.CD001076.
This section is under preparation and will be included in the next issue.
In preterm or low birth weight infants, does early versus late weaning from supplementary oxygen influence mortality, retinopathy of prematurity, lung function, growth or development?
The standard search strategy of the Neonatal Review Group was used. This included searches of the Oxford Database of Perinatal Trials, MEDLINE, previous reviews including cross references, abstracts, conferences and symposia proceedings, expert informants, journal handsearching mainly in the English language. An additional literature search of the MEDLINE, EMBASE, and CINAHL databases was conducted in order to locate any trials in addition to those provided by the Cochrane Controlled Trials Register (CENTRAL/CCTR).
All trials utilising random or quasi-random patient allocation, in which early weaning was compared with late discontinuation of supplemental oxygen in preterm or low birth weight infants, were eligible for inclusion.
The methodological quality of the one eligible trial was assessed independently by each author for the degree of selection, performance, attrition and detection bias. Data regarding clinical outcomes including mortality, retinopathy of prematurity, and long term growth and development were extracted and reviewed independently by each author. Results were compared and differences resolved as required. Data analysis was conducted according to the standards of the Cochrane Neonatal Review Group.
In the single eligible trial of 99 infants with birthweights less than 1650g, there were no significant differences in neonatal death rates or retrolental fibroplasia (any grade or severe) for all infants, or among infants with birth weights of less than 1000g. No other outcome measures specified a priori as clinically meaningful were reported in enough detail or with satisfactory follow-up rates to include in the analysis (early death; chronic lung disease; and long term growth, development, lung or visual function).
REVIEWER'S CONCLUSIONS: The results of this systematic review do not provide strong evidence for either the benefits or harms of early oxygen weaning in preterm/LBW infants. Future research should be directed toward addressing the question of what are the most appropriate target levels of oxygenation, in both the early and late neonatal periods, rather than whether oxygen should be weaned early or late.
本节正在编写中,将在下一期发表。
在早产或低出生体重儿中,早期与晚期停止补充氧气对死亡率、早产儿视网膜病变、肺功能、生长或发育有何影响?
采用新生儿综述组的标准检索策略。这包括检索牛津围产期试验数据库、MEDLINE、以往的综述(包括交叉参考文献、摘要、会议和研讨会论文集)、专家提供的信息、主要以英文进行的期刊手工检索。为了找到除Cochrane对照试验注册库(CENTRAL/CCTR)提供的试验之外的任何试验,还对MEDLINE、EMBASE和CINAHL数据库进行了额外的文献检索。
所有采用随机或半随机患者分配的试验,其中将早产或低出生体重儿早期停止补充氧气与晚期停止补充氧气进行比较的试验均符合纳入标准。
每位作者独立评估一项符合条件的试验的方法学质量,评估内容包括选择、实施、失访和检测偏倚的程度。每位作者独立提取并审查有关临床结局的数据,包括死亡率、早产儿视网膜病变以及长期生长和发育情况。比较结果并根据需要解决差异。数据分析按照Cochrane新生儿综述组的标准进行。
在一项纳入99名出生体重小于1650g婴儿的符合条件的试验中,所有婴儿或出生体重小于1000g的婴儿在新生儿死亡率或晶状体后纤维增生(任何级别或严重级别)方面均无显著差异。没有其他预先指定为具有临床意义的结局指标有足够详细的报告或令人满意的随访率以纳入分析(早期死亡;慢性肺病;以及长期生长、发育、肺或视觉功能)。
本系统综述的结果未提供有力证据证明早产/低出生体重儿早期停止吸氧有益或有害。未来的研究应致力于解决在新生儿早期和晚期最合适的氧合目标水平是多少的问题,而不是氧气应早期还是晚期停止供应。